Pulse Biosciences PLSE
NASDAQ PLSE
$49.34 +1.49 (+3.11%)
As of: Aug 21, 2026 · 2:43 PM EDT

Pulse Biosciences (PLSE) Finished Goods (2021 - 2022)

Pulse Biosciences (PLSE) posted quarterly Finished Goods of $750000.0 for Q3 2022, down 55.91% year-over-year from $1.7 million in Q3 2021, and down 71.0% quarter-over-quarter from $2.6 million in Q2 2022.

Pulse Biosciences (PLSE) Finished Goods (2021 - 2022) Analysis & Trends

Pulse Biosciences' Finished Goods history runs 2 years deep, the most recent figure standing at $750000.0 for Q3 2022.

  • In Q3 2022, Finished Goods fell 55.91% year-over-year to $750000.0; the TTM figure through Sep 2022 stood at $750000.0 (down 55.91% YoY), while the FY2021 annual figure was $2.4 million, changed N/A from the prior year.
  • Finished Goods for Q3 2022 stood at $750000.0, down from $2.6 million in the prior quarter.
  • The five-year high for Finished Goods was $2.7 million in Q1 2022, with the low at $750000.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.25 Bn 129.03 Bn 1.96 Bn
2 Becton Dickinson 52.47 Bn 51.61 Bn 2.32 Bn
3 Alcon 35.69 Bn 34.34 Bn 1.68 Bn
4 Resmed 33.67 Bn 32.20 Bn 861.22 Mn
5 Medline 29.17 Bn 26.49 Bn 2.22 Bn
6 West Pharmaceutical Services 25.06 Bn 24.62 Bn 329.20 Mn
7 Solventum 15.36 Bn 14.95 Bn 1.29 Bn
8 Cooper Companies 14.79 Bn 14.65 Bn 735.40 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn
10 Pulse Biosciences 3.42 Bn 3.42 Bn 161,000.00

Historic Data

Download Data
DateValue
Sep 30, 2022 750,000.00
Jun 30, 2022 2.59 Mn
Mar 31, 2022 2.74 Mn
Dec 31, 2021 2.44 Mn
Sep 30, 2021 1.70 Mn